| Bioactivity | ALPK1-IN-3 is an inhibitor of ALPK1 extracted from patent WO2022063153A1 compound T007. ALPK1-IN-3 inhibits kidney proinflammatory gene expression and improves the survival rate of the animals in sepsis induced acute kidney injury animal model[1]. |
| Name | ALPK1-IN-3 |
| CAS | 2765633-73-4 |
| Formula | C20H16F2N4OS |
| Molar Mass | 398.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Danyang Liu, et.al. Benzothiazole and quinoline derivatives and their use. |
ALPK1-IN-3
CAS: 2765633-73-4 F: C20H16F2N4OS W: 398.43
ALPK1-IN-3 is an inhibitor of ALPK1 extracted from patent WO2022063153A1 compound T007. ALPK1-IN-3 inhibits kidney proin
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.